Cancer Site (ICD-O-3) | Men | Women | ||||
---|---|---|---|---|---|---|
Cases | HR | (95% CI)a | Cases | HR | (95% CI)a | |
Any cancerb | 270 | 0.84 | (0.75–0.95) | 355 | 0.85 | (0.76–0.94) |
Breast (C50) | 0 | - | - | 110 | 0.85 | (0.70–1.02) |
Prostate (C61.9) | 80 | 0.82 | (0.66–1.02) | - | - | - |
Leukemia3 | 80 | 1.08 | (0.60–1.95) | 15 | 2.01 | (1.24–3.25) |
Lung (C34) | 50 | 0.85 | (0.64–1.13) | 30 | 0.44 | (0.31–0.63) |
Melanoma (C44) | <5 | - | - | 25 | 1.79 | (1.17–2.73) |
Colon (C18, C26.0) | 30 | 1.10 | (0.77–1.56) | 20 | 0.62 | (0.39–0.97) |
Rectum (C19.9, C20.9) | 15 | 0.88 | (0.53–1.46) | 15 | 0.96 | (0.58–1.59) |
Non-Hodgkin Lymphomac | 15 | 1.16 | (0.48–2.80) | 15 | 0.74 | (0.47–1.18) |
Bladder (C67) | 15 | 0.75 | (0.47–1.20) | <5 | - | - |
Thyroid (C73.9) | 0 | - | - | 15 | 1.55 | (0.96–2.51) |
Ovary (C56.9) | - | - | - | 15 | 1.08 | (0.66–1.77) |
Cervix (C53) | - | - | - | 10 | 1.13 | (0.59–2.18) |
Multiple Myelomac | 10 | 0.84 | (0.52–1.38) | 10 | 2.25 | (1.16–4.37) |
Kidney (C64.9) | 10 | 0.90 | (0.48–1.68) | 10 | 0.82 | (0.39–1.74) |
Stomach (C16) | 10 | 0.61 | (0.32–1.18) | 10 | 1.05 | (0.50–2.21) |
Oral (C00-C14) | 10 | 1.26 | (0.71–2.22) | 5 | 0.82 | (0.34–1.98) |
 Lip (C00.0-C00.9) | 10 | 3.59 | (1.69–7.62) | 0 | - | - |
Pancreas (C25) | 5 | 0.87 | (0.41–1.83) | 5 | 1.02 | (0.53–1.96) |
Brain (C70-C72) | <5 | - | - | 5 | 1.06 | (0.47–2.37) |
Larynx (C32) | 5 | 1.50 | (0.67–3.36) | 0 | - | - |
Bone (C40, C41) | <5 | - | - | <5 | - | - |
Liver (C22.0, C22.1) | <5 | - | - | 0 | - | - |
Nasal (C30) | <5 | - | - | 0 | - | - |
Esophagus (C15) | 0 | - | - | <5 | - | - |
Mesotheliomac | 0 | - | - | <5 | - | - |
Hodgkin Lymphomac | 0 | - | - | <5 | - | - |
Testis (C62) | 0 | - | - | - | - | - |